Roche presents new Alzheimer’s research at AAIC 2025
Roche also shared the design of its upcoming Phase III TRONTIER 1 and 2 trials investigating trontinemab in people with early symptomatic Alzheimer’s disease
Roche also shared the design of its upcoming Phase III TRONTIER 1 and 2 trials investigating trontinemab in people with early symptomatic Alzheimer’s disease
The company would be commissioning 3 hubs in Q2 FY26 across our Core Geography and West Bengal
Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York
Combined strength of two brands across 11 states to elevate patient care delivery and access to doctors
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
The new Zigly center features and offers comprehensive veterinary services
Plant-based chemistries have an outsized role to play for the HPC sector by meeting demand for good, gentle, and green products
This marks the fourth acquisition by Corona Remedies from multinational corporations
India’s nutraceutical industry is expected to reach over US$ 22 billion in 2025
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
Subscribe To Our Newsletter & Stay Updated